China’s first home-developed anti-COVID-19 drug using “antibody cocktail therapy” has been approved for marketing, after being found to be effective in reducing the risk of hospitalization or death among high-risk COVID-19 patients by 80 percent. It also retains its neutralizing activity against the Omicron variant.
Study compares three types of state legislations aimed at ensuring adequate nurse staffing news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.